These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 24780384

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Yanase T, Tsuneki I, Tamura M, Kurabayashi T.
    Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
    [Abstract] [Full Text] [Related]

  • 23. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study.
    Cho B, Roh JW, Park J, Jeong K, Kim TH, Kim YS, Kwon YS, Cho CH, Park SH, Kim SH.
    Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358
    [Abstract] [Full Text] [Related]

  • 24. Endometriosis: a rare and interesting cause of recurrent haemorrhagic ascites.
    Bignall J, Arambage K, Vimplis S.
    BMJ Case Rep; 2014 Oct 29; 2014():. PubMed ID: 25355738
    [Abstract] [Full Text] [Related]

  • 25. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S, Takagi H, Matsunami K, Suzuki N, Imai A.
    Arch Gynecol Obstet; 2011 Sep 29; 284(3):667-70. PubMed ID: 21052701
    [Abstract] [Full Text] [Related]

  • 26. Ascites due to endometriosis.
    Spitzer M, Benjamin F.
    Obstet Gynecol Surv; 1995 Aug 29; 50(8):628-31. PubMed ID: 7478417
    [Abstract] [Full Text] [Related]

  • 27. Use of dienogest over 53 weeks for the treatment of endometriosis.
    Sugimoto K, Nagata C, Hayashi H, Yanagida S, Okamoto A.
    J Obstet Gynaecol Res; 2015 Dec 29; 41(12):1921-6. PubMed ID: 26369271
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Massive ascites as a presentation in a young woman with endometriosis: a case report.
    Sait KH.
    Fertil Steril; 2008 Nov 29; 90(5):2015.e17-9. PubMed ID: 18778818
    [Abstract] [Full Text] [Related]

  • 31. Successful Treatment of Endometriosis-Related Hemorrhagic Ascites: A Report of Three Cases.
    Mendes S, Carvalho C, Rodrigues G, Barata S, Calhaz-Jorge C, Osório F.
    Surg Technol Int; 2018 Jun 01; 32():150-155. PubMed ID: 29689592
    [Abstract] [Full Text] [Related]

  • 32. Dienogest in the treatment of endometriosis.
    Bizzarri N, Remorgida V, Leone Roberti Maggiore U, Scala C, Tafi E, Ghirardi V, Salvatore S, Candiani M, Venturini PL, Ferrero S.
    Expert Opin Pharmacother; 2014 Sep 01; 15(13):1889-902. PubMed ID: 25069386
    [Abstract] [Full Text] [Related]

  • 33. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis.
    Yamanaka A, Hada T, Matsumoto T, Kanno K, Shirane A, Yanai S, Nakajima S, Ebisawa K, Ota Y, Andou M.
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep 01; 216():51-55. PubMed ID: 28728071
    [Abstract] [Full Text] [Related]

  • 34. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
    Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S.
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec 01; 183():188-92. PubMed ID: 25461377
    [Abstract] [Full Text] [Related]

  • 35. A rare case of massive hemorrhagic ascites secondary to endometriosis.
    Wang H, Cai B, Guo X, Lu W.
    Int J Gynaecol Obstet; 2023 May 01; 161(2):675-677. PubMed ID: 36573393
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study.
    Osuga Y, Hayashi K, Kanda S.
    Fertil Steril; 2020 Jan 01; 113(1):167-175. PubMed ID: 31727415
    [Abstract] [Full Text] [Related]

  • 37. Hormonal Therapies before in vitro fertilization in women with endometriosis: The Minotaur's Labyrinth and the Ariadne's Thread.
    Naem A, Krentel H, Moawad G, Naem J, Venezia R, Etrusco A, Terzic S, Laganà AS.
    Best Pract Res Clin Obstet Gynaecol; 2024 Jul 01; 95():102500. PubMed ID: 38772765
    [Abstract] [Full Text] [Related]

  • 38. Treatment of premenstrual mood changes in a patient with schizophrenia using dienogest: A case report.
    Kamada Y, Sakamoto A, Kotani S, Masuyama H.
    J Obstet Gynaecol Res; 2018 Apr 01; 44(4):797-800. PubMed ID: 29359527
    [Abstract] [Full Text] [Related]

  • 39. Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial.
    Granese R, Perino A, Calagna G, Saitta S, De Franciscis P, Colacurci N, Triolo O, Cucinella G.
    Acta Obstet Gynecol Scand; 2015 Jun 01; 94(6):637-45. PubMed ID: 25761587
    [Abstract] [Full Text] [Related]

  • 40. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
    Ji M, Yuan M, Jiao X, Li Q, Huang Y, Li J, Wang G.
    Gynecol Endocrinol; 2022 Feb 01; 38(2):164-169. PubMed ID: 34749585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.